Cargando…
Detection of SARS-CoV-2 at the point of care
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is the etiologic agent of COVID-19. Testing for SARS-CoV-2 infection is a critical element of the public health response to COVID-19. Point-of-care (POC) tests can drive patient management decisions for infectious diseases, including COVID...
Autores principales: | Loeffelholz, Michael J, Tang, Yi-Wei |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Newlands Press Ltd
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8297542/ https://www.ncbi.nlm.nih.gov/pubmed/34289741 http://dx.doi.org/10.4155/bio-2021-0078 |
Ejemplares similares
-
Evaluation of High-Throughput Serological Tests for SARS-CoV-2
por: Loeffelholz, Michael J.
Publicado: (2020) -
Performance Evaluation of the SAMBA II SARS-CoV-2 Test for Point-of-Care Detection of SARS-CoV-2
por: Assennato, Sonny M., et al.
Publicado: (2020) -
Engineering luminescent biosensors for point-of-care SARS-CoV-2 antibody detection
por: Elledge, Susanna K., et al.
Publicado: (2020) -
Considerations regarding Interpretation of Positive SARS-CoV-2 Molecular Results with Late Cycle Threshold Values
por: Mitchell, Stephanie L., et al.
Publicado: (2022) -
Low-cost biosensor for rapid detection of SARS-CoV-2 at the point of care
por: Torres, Marcelo D.T., et al.
Publicado: (2021)